Biomedical Engineering Reference
In-Depth Information
Mocellin S, Nitti D (2008) Therapeutics targeting tumor immune escape: towards the development
of new generation anticancer vaccines. Med Res Rev 28 (3):413-444. doi:10.1002/med.20110
Mohsin K, Long MA, Pouton CW (2009) Design of lipid-based formulations for oral adminis-
tration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in
aqueous solution. J Pharm Sci 98 (10):3582-3595. doi:10.1002/jps.21659
Mowat AM (2003) Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev
Immunol 3 (4):331-341. doi:10.1038/nri1057 nri1057 [pii]
Murray GI, Melvin WT, Burke MD (1995) Cytochrome P450 expression in tumours. J Pathol 176
(3):323-324
Nazzal S, Smalyukh, II, Lavrentovich OD, Khan MA (2002) Preparation and in vitro characteriza-
tion of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of
ubiquinone: mechanism and progress of emulsion formation. Int J Pharm 235 (1-2):247-265.
doi:S0378517302000030 [pii]
Neudeck BL, Loeb JM, Faith NG, Czuprynski CJ (2004) Intestinal P glycoprotein acts as a natural
defense mechanism against Listeria monocytogenes. Infect Immun 72 (7):3849-3854.
doi:10.1128/IAI.72.7.3849-3854.2004 72/7/3849 [pii]
Ohashi Y, Watanabe T, Sano M, Koyama H, Inaji H, Suzuki T (2010) Efficacy of oral tegafur-
uracil (UFT) as adjuvant therapy as compared with classical cyclophosphamide, methotrexate,
and 5-fluorouracil (CMF) in early breast cancer: a pooled analysis of two randomized con-
trolled trials (N.SAS-BC 01 trial and CUBC trial). Breast Cancer Res Treat 119 (3):633-641.
doi:10.1007/s10549-009-0635-3
Palm K, Luthman K, Ungell AL, Strandlund G, Artursson P (1996) Correlation of drug absorption
with molecular surface properties. J Pharm Sci 85 (1):32-39. doi:10.1021/js950285r 10.1021/
js950285r [pii]
Pasquier E, Kavallaris M, Andre N (2010) Metronomic chemotherapy: new rationale for new direc-
tions. Nat Rev Clin Oncol 7 (8):455-465. doi:nrclinonc.2010.82 [pii] 10.1038/nrclinonc.2010.82
Payne SA (1992) A study of quality of life in cancer patients receiving palliative chemotherapy.
Soc Sci Med 35 (12):1505-1509. doi:10.1016/0277-9536(92)90053-S
Peltier S, Oger JM, Lagarce F, Couet W, Benoit JP (2006) Enhanced oral paclitaxel bioavailability
after administration of paclitaxel-loaded lipid nanocapsules. Pharm Res 23 (6):1243-1250.
doi:10.1007/s11095-006-0022-2
Porter CJ, Trevaskis NL, Charman WN (2007) Lipids and lipid-based formulations: optimizing
the oral delivery of lipophilic drugs. Nat Rev Drug Discov 6 (3):231-248. doi:nrd2197 [pii]
10.1038/nrd2197
Primard C, Rochereau N, Luciani E, Genin C, Delair T, Paul S, Verrier B (2010) Traffic of
poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial
immune competent cells. Biomaterials 31 (23):6060-6068. doi:S0142-9612(10)00504-1 [pii]
10.1016/j.biomaterials.2010.04.021
Rae CS, Khor IW, Wang Q, Destito G, Gonzalez MJ, Singh P, Thomas DM, Estrada MN, Powell
E, Finn MG, Manchester M (2005) Systemic trafficking of plant virus nanoparticles in mice
via the oral route. Virology 343 (2):224-235. doi:S0042-6822(05)00468-X [pii] 10.1016/j.
virol.2005.08.017
Roger E, Lagarce F, Garcion E, Benoit JP (2010) Biopharmaceutical parameters to consider in
order to alter the fate of nanocarriers after oral delivery. Nanomedicine (Lond) 5 (2):287-306.
doi:10.2217/nnm.09.110
Roger E, Lagarce F, Garcion E, Benoit JP (2010) Reciprocal competition between lipid nanocap-
sules and P-gp for paclitaxel transport across Caco-2 cells. Eur J Pharm Sci 40 (5):422-429.
doi:S0928-0987(10)00160-0 [pii] 10.1016/j.ejps.2010.04.015
Salman HH, Gamazo C, Campanero MA, Irache JM (2005) Salmonella-like bioadhesive nano-
particles. J Control Release 106 (1-2):1-13. doi:S0168-3659(05)00115-X [pii] 10.1016/j.
jconrel.2005.03.033
Schellens JH, Malingre MM, Kruijtzer CM, Bardelmeijer HA, van Tellingen O, Schinkel AH,
Beijnen JH (2000) Modulation of oral bioavailability of anticancer drugs: from mouse to man.
Eur J Pharm Sci 12 (2):103-110. doi:S0928-0987(00)00153-6 [pii]
Search WWH ::
Custom Search